Celon Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Celon Pharma has a total shareholder equity of PLN445.6M and total debt of PLN12.8M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are PLN569.3M and PLN123.8M respectively.
Key information
2.9%
Debt to equity ratio
zł12.75m
Debt
Interest coverage ratio | n/a |
Cash | zł32.36m |
Equity | zł445.56m |
Total liabilities | zł123.75m |
Total assets | zł569.31m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8RP's short term assets (PLN189.7M) exceed its short term liabilities (PLN86.3M).
Long Term Liabilities: 8RP's short term assets (PLN189.7M) exceed its long term liabilities (PLN37.4M).
Debt to Equity History and Analysis
Debt Level: 8RP has more cash than its total debt.
Reducing Debt: 8RP's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Debt Coverage: 8RP's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 8RP's interest payments on its debt are well covered by EBIT.